Human Dopaminergic Neuronal Precursor Cell
Cat.No.: CSC-C9341W
Species: Human
Source: Brain
Morphology: Multipolar
Cell Type: Neuron
- Specification
- Background
- Scientific Data
- Q & A
- Customer Review
Human Dopaminergic Neuronal Precursor Cells (hDNPs) are lineage-restricted neural progenitors that differentiate into dopamine-producing neurons of the midbrain. These cells are often derived from human pluripotent stem cells (hESCs or hiPSCs) or fetal neural tissues and represent an important intermediate stage between neural stem cells and mature dopaminergic neurons. hDNPs typically express early neuronal and dopaminergic lineage markers, like Nestin, SOX2, LMX1A, FOXA2, and NURR1, and gradually gain the ability to express tyrosine hydroxylase (TH), the rate-limiting enzyme for dopamine synthesis.
Functionally, hDNPs exhibit high proliferative capacity and can be efficiently induced to differentiate into mature, electrically active dopaminergic neurons under defined culture conditions. Upon differentiation, these neurons exhibit characteristic morphology, elaborate complex neurites, and synthesize and release dopamine. hDNPs are widely used as in vitro models to study midbrain development, neuronal differentiation and dopaminergic lineage specification because of their developmental relevance. These cells are especially valuable for studying neurodegenerative diseases, like Parkinson's, where the loss of dopaminergic neurons is a key feature. They are also used in drug screening, neurotoxicity testing and cell replacement therapy research providing a promising platform for regenerative medicine and CNS drug discovery.
Circulating neuron-derived cfDNA for blood-based detection of Alzheimer’s and other neurodegenerative conditions
Background
This proof-of-concept study demonstrates that native nanopore sequencing can generate a human brain methylation atlas and classify neuron-derived cfDNA from blood plasma. Using six primary neural cell types, the authors developed cell-type-specific classifiers and applied them to 137 plasma samples from Alzheimer’s disease, Parkinson’s disease, ALS, mild cognitive impairment, and controls. Elevated cortical neuron-like cfDNA occurred in AD/MCI, dopaminergic neuron-like cfDNA in PD, and spinal motor neuron-like cfDNA in ALS. Multivariate integration improved diagnostic separation (AUC >0.85). Native sequencing avoids bisulfite/PCR bias, supporting liquid biopsy for neurodegenerative disease.
Key Findings
The study generated a methylation reference atlas from six primary human neural cell populations—cortical neurons, dopaminergic neurons, spinal motor neurons, astrocytes, Schwann cells, and microglia—using whole-genome native nanopore sequencing. This enabled cell-type-specific cfDNA classifiers with high analytical accuracy in in silico dilution series (R² up to 0.998). In 137 plasma samples, classifier signals aligned with selectively vulnerable neurons: cortical neuron-like cfDNA was elevated in AD and progressive MCI (22.27% vs 7.42% controls), dopaminergic neuron-like cfDNA in PD (45.01% vs 10.94%), and spinal motor neuron-like cfDNA in ALS (7.11% vs 2.48%). Multivariate integration of neuronal signatures improved disease discrimination, achieving AUC >0.85 in multi-disease comparisons. iPSC-derived neuron classifiers failed to replicate disease signals, highlighting the value of primary-cell references. The work supports native cfDNA nanopore methylation sequencing as a flexible platform for cell-of-origin analysis in neurodegeneration.
Contribution
Creative Bioarray supplied purified human neural cell populations, including primary and iPSC-derived cortical and dopaminergic neurons and glial cells, used to generate the whole-genome nanopore methylation reference atlas. These reference methylomes enabled development of cell-type-specific cfDNA classifiers for neurodegeneration analysis.
Uptake of LUHMES-Derived EVs by Astrocytes (ACs) and Microglia (MG)
Psychological stress and depression are linked to elevated interleukin-6 (IL-6), which modulates extracellular vesicle (EV) secretion. MicroRNAs (miRNAs) within EVs regulate gene expression in recipient cells upon endocytosis. Here, Nishi et al. investigated the effect of IL-6 on EVs secreted by the human dopaminergic neuronal precursor cell line (LUHMES cells).
They first characterized EV markers by measuring tetraspanin proteins in media and mRNA levels in LUHMES, astrocytes (ACs), and microglia (MG) using ELISA (Fig. 1A) and real-time PCR (Fig. 1B). While all cells expressed the three tetraspanins, no correlation was found between protein levels in the medium and cellular mRNA expression.
Next, they assessed EV uptake. Media from LUHMES cells expressing CD81-Nluc was applied to ACs and MG. Expression of CD81-Nluc did not alter endogenous tetraspanin levels in EVs (Fig. 2A), suggesting normal uptake kinetics. NanoLuc (Nluc) activity reflects the net balance of EV uptake, degradation, and recycling. Time-course analysis showed that Nluc activity in both ACs and MG peaked at 4 h and stabilized after 8 h (Fig. 2B), indicating an equilibrium state. Consequently, we compared EV uptake at the 8‑h time point. As shown in Figure 2C, ACs exhibited higher Nluc activity than MG, suggesting that astrocytes receive more EV-mediated signals from LUHMES cells than microglia.


Ask a Question
Write your own review